apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

Molecular tumor board—renal cell carcinoma Molekulares Tumorboard – Nierenzellkarzinom (2019) Grünwald V, Doehn C, Goebell P Journal article, Review article Treatment situation in metastastic Castration Naive Prostate Cancer (mCRPC) and the implications on clinical routine Therapiesituation beim metastasierten kastrationsnaiven Prostatakarzinom (mCNPC) und die Auswirkungen im klinischen Alltag (2019) Wülfing C, Bögemann M, Goebell P, Hammerer P, Machtens S, Pfister D, Schwentner C, et al. Journal article, Review article New horizons in bladder cancer research (2019) Boormans JL, Zwarthoff EC, Black PC, Goebell P, Kamat AM, Nawroth R, Seiler R, et al. Journal article, Review article Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1 (2019) Black PC, Goebell P, Kamat AM, Nawroth R, Seiler R, Williams SB, Schmitz-Dräger BJ Journal article Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study (2019) Goebell P, Hermann E, Kube U, Doehn C, Marschner N, Dietel A, Blumenstengel K, et al. Journal article New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21-23, 2017 (2018) Black PC, Goebell P, Kamat AM, Nawroth R, Schmitz-Draeger BJ Journal article RECREATE: Treatment reality for mRCCpatients following first line Pazopanib therapy - a retrospective chart review (2018) Hegele A, Von Der Heyde E, Goebell P, Huebner A, Zengerling F, Klier J, Belz H, et al. Conference contribution Prospective evaluation of geriatric assessment tools as predictors of functional outcome in old patients undergoing major urologic tumor surgery (2018) Kahlmeyer A, Losensky W, Sikic D, Wach S, Ritt M, Goebell P, Keck B, Wullich B Conference contribution Non-invasive bladder cancer (2018) Burger M, Schwaibold H, Goebell P, Grimm MO Journal article Metastatic castration-resistant prostate cancer. Use of cabazitaxel taking into consideration current data (2018) Gschwend JE, Albers P, Boegemann M, Goebell P, Heidenreich A, Klier J, Koenig F, et al. Journal article